Maat Pharma Is A Clinical Stage Biotechnology Company Focused On Developing Microbiome Therapeuticsparticularly For Oncologyfounded About Ten Years Agothe Company Targets Severe Oncology Diseaseswith A Special Emphasis On Acute Graft Versus Host Diseaseagvhd Maat Pharma Employs A Unique Full Ecosystem Approach To Restore Patient Microbiome Symbiosiswhich Sets It Apart In The Oncology Field The Company S Lead Productmaat013Has Completed Phase 3 Trials And Is Poised For Commercializationit Has Shown A Significant Improvement In One Year Survival Rates For Patients With Third Line Agvhdincreasing From 15To 54 Maat Pharma Also Offers Microbiome Restoration Services Aimed At Enhancing The Immune System In Cancer Patientsadditionallythe Company Utilizes Artificial Intelligence To Refine Its Microbiome Driven Therapiesimproving Their Precision And Effectivenessrecent Developments Include A Successful Capital Raisemembership In The Microbiome Therapeutics Innovation Groupand The Completion Of A Cgmp Manufacturing Facility To Boost Production Capabilities
